Concepedia

Publication | Closed Access

Enhancement of Alkylating Agent Activity by SR-4233 in the FSaIIC Muraine Fibrosarcoma

DOI

42

Citations

0

References

1992

Year

S. A. Holden, B. A. Teicher, Gulshan Ara, TS Herman, C.Norman Coleman
JNCI Journal of the National Cancer Institute

Abstract

Our results suggest that SR-4233 may have the potential to improve the clinical efficacy of commonly used antitumor alkylating agents.